Publications searcher

The science produced by our scientists is very important. In 2022, 1,629 papers were published in scientific journals with a global impact factor of over 15,000 points.

Perceptions of diabetes obtained through drawing in childhood and adolescence.

PMID: 23814467
Journal: Patient Preference and Adherence
Year: 2013
Reference: Patient Prefer Adherence. 2013 Jun 20;7:595-605. doi: 10.2147/PPA.S45130. Print 2013.
Impact factor: 1.333
Publication type: Paper in international publication
Authors: Isla Pera, Pilar, Palacin Lois, Maria, Lopez Matheu, Carmen, Honrubia Perez, Maria, Gomez Rodriguez, Ana Maria, Armengol Camps, Eulalia, Sanchez Villalba, Carmen, Insa Soria, Roser, Rigol Cuadra, Assumpta, Marre, Diana et al.
DOI: 10.2147/PPA.S45130

Perceptions of diabetes obtained through drawing in childhood and adolescence.

PMID: 23814467
Journal: Patient Preference and Adherence
Year: 2013
Reference: Patient Prefer Adherence. 2013 Jun 20;7:595-605. doi: 10.2147/PPA.S45130. Print 2013.
Impact factor:
Publication type: Paper in international publication
Authors: Armengol Camps, Eulalia; Gomez Rodriguez, Ana Maria; Honrubia Perez, Maria; Insa Soria, Roser; Isla Pera, Pilar; Lopez Matheu, Carmen; Marre, Diana; Palacin Lois, Maria; Rigol Cuadra, Assumpta; Sanchez Villalba, Carmen et al.
DOI: 10.2147/PPA.S45130

Percutaneous computed tomography-guided resection of non-spinal osteoid osteomas in 54 patients and review of the literature.

PMID: 23354882
Journal: ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY
Year: 2013
Reference: Arch Orthop Trauma Surg. 2013 Apr;133(4):449-55. doi: 10.1007/s00402-013-1686-9. Epub 2013 Jan 25.
Impact factor: 1.358
Publication type: Review in international publication
Authors: Reverte-Vinaixa, Maria Mercedes, Velez, Roberto, Alvarez, Sonia, Rivas, A, Perez, Manuel et al.
DOI: 10.1007/s00402-013-1686-9

Percutaneous computed tomography-guided resection of non-spinal osteoid osteomas in 54 patients and review of the literature.

PMID: 23354882
Journal: ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY
Year: 2013
Reference: Arch Orthop Trauma Surg. 2013 Apr;133(4):449-55. doi: 10.1007/s00402-013-1686-9. Epub 2013 Jan 25.
Impact factor:
Publication type: Review in international publication
Authors: Alvarez, Sonia; Perez, Manuel; Reverte-Vinaixa, Maria Mercedes; Rivas, A; Velez, Roberto et al.
DOI: 10.1007/s00402-013-1686-9

Perfusion MRI: The Five Most Frequently Asked Clinical Questions.

PMID: 23971482
Journal: AMERICAN JOURNAL OF ROENTGENOLOGY
Year: 2013
Reference: AJR Am J Roentgenol. 2013 Sep;201(3):W495-510. doi: 10.2214/AJR.12.9544.
Impact factor: 2.897
Publication type: Review in international publication
Authors: Law, Meng, Wintermark, Max, Rovira, Alex, Dorfler, Arnd, Anzalone, Nicoletta, Essig, Marco, Nguyen, Thanh Binh, Shiroishi, Mark S, Saake, Marc, Provenzale, James M et al.
DOI: 10.2214/AJR.12.9544

Perfusion MRI: The Five Most Frequently Asked Clinical Questions.

PMID: 23971482
Journal: AMERICAN JOURNAL OF ROENTGENOLOGY
Year: 2013
Reference: AJR Am J Roentgenol. 2013 Sep;201(3):W495-510. doi: 10.2214/AJR.12.9544.
Impact factor:
Publication type: Review in international publication
Authors: Anzalone, Nicoletta; Dorfler, Arnd; Enterline, David S; Essig, Marco; Law, Meng; Nguyen, Thanh Binh; Provenzale, James M; Rovira, Alex; Saake, Marc; Shiroishi, Mark S et al.
DOI: 10.2214/AJR.12.9544

Perfusion MRI: the five most frequently asked technical questions.

PMID: 23255738
Journal: AMERICAN JOURNAL OF ROENTGENOLOGY
Year: 2013
Reference: AJR Am J Roentgenol. 2013 Jan;200(1):24-34. doi: 10.2214/AJR.12.9543.
Impact factor: 2.897
Publication type: Review in international publication
Authors: Provenzale, James M, Essig, Marco, Shiroishi, Mark S, Nguyen, Thanh Binh, Saake, Marc, Dorfler, Arnd, Rovira, Alex, Wintermark, Max, Law, Meng, Anzalone, Nicoletta et al.
DOI: 10.2214/AJR.12.9543

Perfusion MRI: the five most frequently asked technical questions.

PMID: 23255738
Journal: AMERICAN JOURNAL OF ROENTGENOLOGY
Year: 2013
Reference: AJR Am J Roentgenol. 2013 Jan;200(1):24-34. doi: 10.2214/AJR.12.9543.
Impact factor:
Publication type: Review in international publication
Authors: Anzalone, Nicoletta; Dorfler, Arnd; Enterline, David; Essig, Marco; Law, Meng; Nguyen, Thanh Binh; Provenzale, James M; Rovira, Alex; Saake, Marc; Shiroishi, Mark S et al.
DOI: 10.2214/AJR.12.9543

Periprosthetic fractures around the knee-the best way of treatment.

PMID: 23667400
Journal: European orthopaedics and traumatology
Year: 2013
Reference: Eur Orthop Traumatol. 2013 Jun;4(2):93-102. Epub 2012 Aug 21.
Impact factor: 0
Publication type: Paper in international publication
Authors: Ruchholtz, Steffen, Tomas, Jordi, Gebhard, Florian, Larsen, Morten Schultz et al.
DOI: 10.1007/s12570-012-0130-x

Periprosthetic fractures around the knee-the best way of treatment.

PMID: 23667400
Journal: European orthopaedics and traumatology
Year: 2013
Reference: Eur Orthop Traumatol. 2013 Jun;4(2):93-102. Epub 2012 Aug 21.
Impact factor:
Publication type: Paper in international publication
Authors: Gebhard, Florian; Larsen, Morten Schultz; Ruchholtz, Steffen; Tomas, Jordi et al.
DOI: 10.1007/s12570-012-0130-x

Personalized approach to growth hormone treatment: clinical use of growth prediction models.

PMID: 23735882
Journal: Hormone Research in Paediatrics
Year: 2013
Reference: Horm Res Paediatr. 2013;79(5):257-70. doi: 10.1159/000351025. Epub 2013 May 28.
Impact factor: 1.553
Publication type: Paper in international publication
Authors: Roelants, M, Dahlgren, J, Wit, J M, Ranke, M B, Albertsson-Wikland, K, Carrascosa, A, Rosenfeld, R G, Van Buuren, S, Kristrom, B, Schoenau, E et al.
DOI: 10.1159/000351025

Personalized approach to growth hormone treatment: clinical use of growth prediction models.

PMID: 23735882
Journal: Hormone Research in Paediatrics
Year: 2013
Reference: Horm Res Paediatr. 2013;79(5):257-70. doi: 10.1159/000351025. Epub 2013 May 28.
Impact factor:
Publication type: Paper in international publication
Authors: Albertsson-Wikland, K; Audi, L; Bang, P; Blum, W F; Carrascosa, A; Cianfarani, S; Clayton, P E; Cohen, P; Dahlgren, J; de Graaff, L et al.
DOI: 10.1159/000351025

Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA).

PMID: 23704196
Journal: ANNALS OF ONCOLOGY
Year: 2013
Reference: Ann Oncol. 2013 Sep;24(9):2278-84. doi: 10.1093/annonc/mdt182. Epub 2013 May 22.
Impact factor: 7.384
Publication type: Paper in international publication
Authors: Schneeweiss, A, Chia, S, Hickish, T, Harvey, V, Eniu, A, Hegg, R, Tausch, C, Seo, J H, Tsai, Y-F, Ratnayake, J et al.
DOI: 10.1093/annonc/mdt182

Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA).

PMID: 23704196
Journal: ANNALS OF ONCOLOGY
Year: 2013
Reference: Ann Oncol. 2013 Sep;24(9):2278-84. doi: 10.1093/annonc/mdt182. Epub 2013 May 22.
Impact factor:
Publication type: Paper in international publication
Authors: Chia, S; Cortes, J; Eniu, A; Harvey, V; Hegg, R; Hickish, T; McNally, V; Ratnayake, J; Ross, G; Schneeweiss, A et al.
DOI: 10.1093/annonc/mdt182

Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study.

PMID: 23602601
Journal: LANCET ONCOLOGY
Year: 2013
Reference: Lancet Oncol. 2013 May;14(6):461-71. doi: 10.1016/S1470-2045(13)70130-X. Epub 2013 Apr 18.
Impact factor: 25.117
Publication type: Paper in international publication
Authors: Swain, Sandra M, Kim, Sung-Bae, Cortes, Javier, Ro, Jungsil, Semiglazov, Vladimir, Campone, Mario, Ciruelos, Eva, Ferrero, Jean-Marc, Schneeweiss, Andreas, Knott, Adam et al.
DOI: 10.1016/S1470-2045(13)70130-X

Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study.

PMID: 23602601
Journal: LANCET ONCOLOGY
Year: 2013
Reference: Lancet Oncol. 2013 May;14(6):461-71. doi: 10.1016/S1470-2045(13)70130-X. Epub 2013 Apr 18.
Impact factor:
Publication type: Paper in international publication
Authors: Baselga, Jose; Benyunes, Mark C; Campone, Mario; Ciruelos, Eva; Clark, Emma; Cortes, Javier; Ferrero, Jean-Marc; Kim, Sung-Bae; Knott, Adam; Ro, Jungsil et al.
DOI: 10.1016/S1470-2045(13)70130-X

Phase I, Pharmacokinetic and Pharmacodynamic Study of the First-in-Class Spliceosome Inhibitor E7107 in Patients with Advanced Solid Tumors.

PMID: 23983259
Journal: CLINICAL CANCER RESEARCH
Year: 2013
Reference: Clin Cancer Res. 2013 Nov 15;19(22):6296-304. doi: 10.1158/1078-0432.CCR-13-0485. Epub 2013 Aug 27.
Impact factor: 7.837
Publication type: Paper in international publication
Authors: de Jonge, Maja J A, Piera, Adelaida, O'Brien, James P, Burger, Herman, Ramos, Francisco J, Eskens, Ferry A L M, Mizui, Yoshiharu, Carreras, Maria Josepa, Wiemer, Erik Ac, Baselga, Jose et al.
DOI: 10.1158/1078-0432.CCR-13-0485

Phase I, Pharmacokinetic and Pharmacodynamic Study of the First-in-Class Spliceosome Inhibitor E7107 in Patients with Advanced Solid Tumors.

PMID: 23983259
Journal: CLINICAL CANCER RESEARCH
Year: 2013
Reference: Clin Cancer Res. 2013 Nov 15;19(22):6296-304. doi: 10.1158/1078-0432.CCR-13-0485. Epub 2013 Aug 27.
Impact factor:
Publication type: Paper in international publication
Authors: Baselga, Jose; Burger, Herman; Carreras, Maria Josepa; de Jonge, Maja J A; Eskens, Ferry A L M; Mizui, Yoshiharu; O'Brien, James P; Piera, Adelaida; Ramos, Francisco J; Tabernero, Josep et al.
DOI: 10.1158/1078-0432.CCR-13-0485

Phase I study of weekly kahalalide F as prolonged infusion in patients with advanced solid tumors.

PMID: 23645288
Journal: CANCER CHEMOTHERAPY AND PHARMACOLOGY
Year: 2013
Reference: Cancer Chemother Pharmacol. 2013 Jul;72(1):75-83. doi: 10.1007/s00280-013-2170-5. Epub 2013 May 5.
Impact factor: 2.795
Publication type: Paper in international publication
Authors: Casado, E, Salazar, R, Cortes-Funes, H, Cuadra, C, Tabernero, J, Coronado, C, Garcia, M, Soto Matos-Pita, A, Miguel-Lillo, B, Cullell-Young, M et al.
DOI: 10.1007/s00280-013-2170-5

Phase I study of weekly kahalalide F as prolonged infusion in patients with advanced solid tumors.

PMID: 23645288
Journal: CANCER CHEMOTHERAPY AND PHARMACOLOGY
Year: 2013
Reference: Cancer Chemother Pharmacol. 2013 Jul;72(1):75-83. doi: 10.1007/s00280-013-2170-5. Epub 2013 May 5.
Impact factor:
Publication type: Paper in international publication
Authors: Casado, E; Coronado, C; Cortes-Funes, H; Cuadra, C; Cullell-Young, M; Garcia, M; Iglesias Dios, J L; Lopez-Martin, A; Miguel-Lillo, B; Pardo, B et al.
DOI: 10.1007/s00280-013-2170-5

Phase II open-label study to assess efficacy and safety of lenalidomide in combination with cetuximab in KRAS-mutant metastatic colorectal cancer.

PMID: 24244261
Journal: PLoS One
Year: 2013
Reference: PLoS One. 2013 Nov 11;8(11):e62264. doi: 10.1371/journal.pone.0062264. eCollection 2013.
Impact factor: 3.73
Publication type: Paper in international publication
Authors: Siena, Salvatore, Van Cutsem, Eric, Li, Mingyu, Jungnelius, Ulf, Romano, Alfredo, Beck, Robert, Bencardino, Katia, Elez, Maria Elena, Prenen, Hans, Sanchis, Mireia et al.
DOI: 10.1371/journal.pone.0062264

Phase II open-label study to assess efficacy and safety of lenalidomide in combination with cetuximab in KRAS-mutant metastatic colorectal cancer.

PMID: 24244261
Journal: PLoS One
Year: 2013
Reference: PLoS One. 2013 Nov 11;8(11):e62264. doi: 10.1371/journal.pone.0062264. eCollection 2013.
Impact factor:
Publication type: Paper in international publication
Authors: Beck, Robert; Bencardino, Katia; Elez, Maria Elena; Gandhi, Anita; Jungnelius, Ulf; Li, Mingyu; Prenen, Hans; Romano, Alfredo; Sanchis, Mireia; Sartore-Bianchi, Andrea et al.
DOI: 10.1371/journal.pone.0062264

Phase II study of everolimus in patients with metastatic colorectal adenocarcinoma previously treated with bevacizumab-, fluoropyrimidine-, oxaliplatin-, and irinotecan-based regimens.

PMID: 23743569
Journal: CLINICAL CANCER RESEARCH
Year: 2013
Reference: Clin Cancer Res. 2013 Jul 15;19(14):3987-95. doi: 10.1158/1078-0432.CCR-13-0027. Epub 2013 Jun 6.
Impact factor: 7.837
Publication type: Paper in international publication
Authors: Ng, Kimmie, Tabernero, Josep, Hwang, Jimmy, Bajetta, Emilio, Sharma, Sunil, Del Prete, Salvatore A, Arrowsmith, Edward R, Ryan, David P, Sedova, Michaela, Jin, Jin et al.
DOI: 10.1158/1078-0432.CCR-13-0027

Phase II study of everolimus in patients with metastatic colorectal adenocarcinoma previously treated with bevacizumab-, fluoropyrimidine-, oxaliplatin-, and irinotecan-based regimens.

PMID: 23743569
Journal: CLINICAL CANCER RESEARCH
Year: 2013
Reference: Clin Cancer Res. 2013 Jul 15;19(14):3987-95. doi: 10.1158/1078-0432.CCR-13-0027. Epub 2013 Jun 6.
Impact factor:
Publication type: Paper in international publication
Authors: Arrowsmith, Edward R; Bajetta, Emilio; Del Prete, Salvatore A; Fuchs, Charles S; Hwang, Jimmy; Jin, Jin; Malek, Kamel; Ng, Kimmie; Ryan, David P; Sedova, Michaela et al.
DOI: 10.1158/1078-0432.CCR-13-0027

Publications

Publications searcher

Perceptions of diabetes obtained through drawing in childhood and adolescence.

Perceptions of diabetes obtained through drawing in childhood and adolescence.

Percutaneous computed tomography-guided resection of non-spinal osteoid osteomas in 54 patients and review of the literature.

Percutaneous computed tomography-guided resection of non-spinal osteoid osteomas in 54 patients and review of the literature.

Perfusion MRI: The Five Most Frequently Asked Clinical Questions.

Perfusion MRI: The Five Most Frequently Asked Clinical Questions.

Perfusion MRI: the five most frequently asked technical questions.

Perfusion MRI: the five most frequently asked technical questions.

Periprosthetic fractures around the knee-the best way of treatment.

Periprosthetic fractures around the knee-the best way of treatment.

Personalized approach to growth hormone treatment: clinical use of growth prediction models.

Personalized approach to growth hormone treatment: clinical use of growth prediction models.

Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA).

Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA).

Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study.

Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study.

Phase I, Pharmacokinetic and Pharmacodynamic Study of the First-in-Class Spliceosome Inhibitor E7107 in Patients with Advanced Solid Tumors.

Phase I, Pharmacokinetic and Pharmacodynamic Study of the First-in-Class Spliceosome Inhibitor E7107 in Patients with Advanced Solid Tumors.

Phase I study of weekly kahalalide F as prolonged infusion in patients with advanced solid tumors.

Phase I study of weekly kahalalide F as prolonged infusion in patients with advanced solid tumors.

Phase II open-label study to assess efficacy and safety of lenalidomide in combination with cetuximab in KRAS-mutant metastatic colorectal cancer.

Phase II open-label study to assess efficacy and safety of lenalidomide in combination with cetuximab in KRAS-mutant metastatic colorectal cancer.

Phase II study of everolimus in patients with metastatic colorectal adenocarcinoma previously treated with bevacizumab-, fluoropyrimidine-, oxaliplatin-, and irinotecan-based regimens.

Phase II study of everolimus in patients with metastatic colorectal adenocarcinoma previously treated with bevacizumab-, fluoropyrimidine-, oxaliplatin-, and irinotecan-based regimens.

Patronage:

Collaborating:

Accreditations: